Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 8/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 8/20 | 1.00 |
| ▸ | BLM | P54132 | 7/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 3/20 | 1.00 |
| ▸ | HTT | P42858 | 3/20 | 1.00 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 1.00 |
| ▸ | ECE1 | P42892 | 1/20 | 1.00 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 1.00 |
| ▸ | THRB | P10828 | 7/20 | 0.79 |
| ▸ | RECQL | P46063 | 6/20 | 0.79 |
| ▸ | HIF1A | Q16665 | 6/20 | 0.79 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.79 |
| ▸ | BRCA1 | P38398 | 6/20 | 0.79 |
| ▸ | TOP2A | P11388 | 5/20 | 0.79 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.79 |
| ▸ | MAPT | P10636 | 5/20 | 0.79 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.79 |
| ▸ | STAT6 | P42226 | 4/20 | 0.79 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.79 |
| ▸ | TBXA2R | P21731 | 3/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pirarubicin SCHEMBL31499425 | 1.00 | MEN1 (1.00) | MEN1KMT2ABLMPTGS1HTT | |
| Pirarubicin SCHEMBL13421276 | 1.00 | MEN1 (1.00) | MEN1KMT2ABLMPTGS1HTT | |
| Pirarubicin SCHEMBL8323 | 1.00 | MEN1 (1.00) | MEN1KMT2ABLMPTGS1HTT | |
| Pirarubicin SCHEMBL29363840 | 1.00 | MEN1 (1.00) | MEN1KMT2ABLMPTGS1HTT | |
| Pirarubicin SCHEMBL12257450 | 1.00 | MEN1 (1.00) | MEN1KMT2ABLMPTGS1HTT | |
| Pirarubicin SCHEMBL15472856 | 1.00 | MEN1 (1.00) | MEN1KMT2ABLMPTGS1HTT | |
| Pirarubicin SCHEMBL12202618 | 1.00 | MEN1 (1.00) | MEN1KMT2ABLMPTGS1HTT | |
| Pirarubicin SCHEMBL6314144 | 1.00 | MEN1 (1.00) | MEN1KMT2ABLMPTGS1HTT | |
| Pirarubicin SCHEMBL31238420 | 0.99 | MEN1 (0.99) | MEN1KMT2ABLMPTGS1HTT | |
| Pirarubicin SCHEMBL99651 | 0.99 | MEN1 (0.99) | MEN1KMT2ABLMPTGS1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 51593 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4748859-A2 | CHEMICALLY AND PHOTOCHEMICALLY INITIATED CELL MEMBRANE BLEBBING TO INDUCE CELL VESICLE PRODUCTION, MODIFICATIONS THEREOF, AND USES THEREOF | The Regents of the University of California (US) | 2026-05-27 | — | — | EP | claimed |
| US-20260137794-A1 | LIGAND-DRUG CONJUGATE AND USE THEREOF | SYSTIMMUNE INC (US) | 2026-05-21 | — | — | US | claimed |
| EP-4743490-A1 | HUMANIZED ANTI-CD7 ANTIBODY | Christian-Albrechts-Universität zu Kiel (DE) | 2026-05-20 | — | — | EP | claimed |
| EP-4744680-A1 | TARGETED CHEMICAL DRUG AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND USE OF TARGETED CHEMICAL DRUG | Bai Yao Zhi Da (Beijing) Nanobio Technology Co., Ltd. (CN) | 2026-05-20 | — | — | EP | claimed |
| CN-122056884-A | Methods of treating pancreatic cancer | 坎莫森特里克斯公司 | 2026-05-19 | — | — | CN | claimed |
| WO-2026099502-A1 | NOVEL DRUG CONJUGATES FOR TESTING CELLULAR DRUG UPTAKE | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2026-05-15 | — | — | WO | claimed |
| EP-4737898-A2 | SEPARATION AND ISOLATION OF NUCLEIC ACIDS USING AFFINITY LIGANDS BOUND TO A SOLID SURFACE | EMP Biotech GmbH (DE) | 2026-05-06 | — | — | EP | claimed |
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| EP-4727589-A1 | PROTAMINE-COATED NUCLEIC ACID/THERAPEUTIC AGENT COMPLEXES, AND USES THEREOF | The Regents of the University of California (US) | 2026-04-22 | — | — | EP | claimed |
| WO-1999001118-A9 | ANTIOXIDANT ENHANCEMENT OF THERAPY FOR HYPERPROLIFERATIVE CONDITIONS | ATHEROGENICS INC (US) | 1999-05-20 | — | — | WO | claimed |
| US-5874412-A | ANTICANCER AGENTS | PRIEBE WALDEMAR (US) | 1999-02-23 | — | — | US | claimed |
| WO-1999001118-A2 | ANTIOXIDANT ENHANCEMENT OF THERAPY FOR HYPERPROLIFERATIVE CONDITIONS | ATHEROGENICS, INC. (US) | 1999-01-14 | — | — | WO | claimed |
| WO-1998032718-A1 | NEW FATTY ACID DERIVATIVES | NORSK HYDRO ASA (NO) | 1998-07-30 | — | — | WO | claimed |
| CN-1165518-A | Novel anthracycline derivatives and pharmaceutical preparations thereof | JAPAN SCIONCE AND TECHNOLOGY C (JP) | 1997-11-19 | — | — | CN | claimed |
| WO-1997034612-A1 | BIS-ANTHRACYCLINES WITH HIGH ACTIVITY AGAINST DOXORUBICIN RESISTANT TUMORS | PRIEBE WALDEMAR (US) | 1997-09-25 | — | — | WO | claimed |
| EP-0795561-A1 | NOVEL ANTHRACYCLINE COMPOUND DERIVATIVES AND MEDICINAL PREPARATIONS CONTAINING THE SAME | Japan Science and Technology Corporation (JP) | 1997-09-17 | — | — | EP | claimed |
| EP-0393575-B1 | Neoplasia treatment compositions containing antineoplastic agent and side-effect reducing protective agent | SEARLE & CO (US) | 1994-03-16 | — | — | EP | claimed |
| WO-1993005774-A1 | COMPLEXES OF ANTHRACYCLINE ANTIBIOTICS WITH POLYUNSATURATED FATTY ACIDS IN LIPID EMULSIONS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1993-04-01 | — | — | WO | claimed |
| EP-0393575-A1 | Neoplasia treatment compositions containing antineoplastic agent and side-effect reducing protective agent | G.D. Searle & Co. (US) | 1990-10-24 | — | — | EP | claimed |